모바일 감마 카메라 시장 규모, 점유율, 동향, 예측 : 제품, 용도, 최종사용자, 지역별(2025-2033년)

The global mobile gamma cameras market size was valued at USD 57.8 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 79.2 Million by 2033, exhibiting a CAGR of 3.39% from 2025-2033. North America currently dominates the market, holding a market share of over 35.0% in 2024. The advancements in medical imaging technology, rising prevalence of chronic diseases, increasing demand for portable diagnostic devices, growing adoption in oncology and cardiology applications, and supportive government healthcare initiatives are some of the factors driving the market in North America.

A mobile gamma camera refers to a portable medical apparatus that generates functional scans of different organs by detecting the gamma rays emitted from the body. The common body parts that are scanned using this apparatus include the brain, heart, kidneys, breasts, liver, lungs and pancreas. The camera works by injecting a radioactive drug or radionucleotide into the body or a particular organ. This aids in recording the consequent radioactivity using the gamma cameras within a very short time. For smaller organs, the apparatus utilizes small detectors with a reduced field of view, thus providing a very precise image output. The major components of the mobile gamma camera system include a collimator, scintillator, photomultiplier tube and computer. Moreover, since the apparatus is portable, it facilitates scanning patients at the bedside, thus offering greater convenience.

Mobile Gamma Cameras Market Trends:

The market is primarily driven by the increasing prevalence of chronic diseases. Besides this, the growing incidences of cancer and a considerable rise in the requirement for gamma camera devices during radio-guided surgery are driving the product demand on the global level. In line with this, continual technological advancements in medical imaging options, such as nuclear imaging and the emergence of solid-state technology, are positively impacting the market. The growing trend of miniaturization of medical devices is acting as another significant growth-inducing factor for the market. The market is further driven by the increasing healthcare expenditure across the globe. Some of the other factors that are providing an impetus to the market growth include the inflating disposable incomes of the masses, the rising product awareness, significant improvements in the healthcare sector and extensive research and development (R&D) activities conducted by key players.

Key Market Segmentation:

Breakup by Product:

• Single-head Mobile Gamma Cameras
• Dual-head Mobile Gamma Cameras
• Triple-head Mobile Gamma Cameras
• Handheld Mobile Gamma Camera

Breakup by Application:

• Cardiac Imaging
• Breast Imaging
• Thyroid Scanning
• Kidney Scanning
• Intraoperative Imaging
• Brain Imaging
• Others

Breakup by End User:

• Hospitals
• Ambulatory Surgical Centers
• Research Centers
• Imaging Centers and Clinics

Breakup by Region:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

Key Questions Answered in This Report

• 1.What are mobile gamma cameras?
• 2.How big is the mobile gamma cameras market?
• 3.What is the expected growth rate of the global mobile gamma cameras market during 2025-2033?
• 4.What are the key factors driving the global mobile gamma cameras market?
• 5.What is the leading segment of the global mobile gamma cameras market based on product?
• 6.What is the leading segment of the global mobile gamma cameras market based on application?
• 7.What is the leading segment of the global mobile gamma cameras market based on end user?
• 8.What are the key regions in the global mobile gamma cameras market?
• 9.Who are the key players/companies in the global mobile gamma cameras market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Mobile Gamma Cameras Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Single-head Mobile Gamma Cameras
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Dual-head Mobile Gamma Cameras
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Triple-head Mobile Gamma Cameras
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Handheld Mobile Gamma Camera
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast

7 Market Breakup by Application

• 7.1 Cardiac Imaging
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Breast Imaging
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Thyroid Scanning
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Kidney Scanning
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast
• 7.5 Intraoperative Imaging
  • 7.5.1 Market Trends
  • 7.5.2 Market Forecast
• 7.6 Brain Imaging
  • 7.6.1 Market Trends
  • 7.6.2 Market Forecast
• 7.7 Others
  • 7.7.1 Market Trends
  • 7.7.2 Market Forecast

8 Market Breakup by End User

• 8.1 Hospitals
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Ambulatory Surgical Centers
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Research Centers
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Imaging Centers and Clinics
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 CMR Naviscan Corporation
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
  • 14.3.2 Crystal Photonics GmbH
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
  • 14.3.3 DDD-Diagnostic A/S
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
  • 14.3.4 Digirad Corporation
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
  • 14.3.5 Dilon Medical Technologies Inc.
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
  • 14.3.6 GAEDE Medizinsysteme GmbH
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
  • 14.3.7 Mediso Ltd.
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
  • 14.3.8 MiE GmbH
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
  • 14.3.9 Oncovision Inc.
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
  • 14.3.10 Siemens AG
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
    • 14.3.10.3 Financials
    • 14.3.10.4 SWOT Analysis
  • 14.3.11 Spectrum Dynamics Medical (Biosensors International Group Ltd.)
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio